Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A

NCT02610127 · clinicaltrials.gov ↗

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Hemophilia A

Interventions

BIOLOGICAL: OBIZUR

Sponsor

Baxalta now part of Shire

Collaborators

[object Object]